DJIA 16,472.37 200.36 1.23%
NASDAQ 4,707.78 80.69 1.74%
S&P 500 1,951.36 27.54 1.43%
market minute promo

11.62 0.56 (5.06%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VNDA $11.62 5.06%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $10.94
Previous Close $11.06
Daily Range $10.79 - $11.67
52-Week Range $8.34 - $15.51
Market Cap $491.4M
P/E Ratio 6.91
Dividend (Yield) $0.00 (0.0%)
Volume 920,178
Average Daily Volume 882,900
Current FY EPS -$0.57




Drug Makers

Vanda Pharmaceuticals, Inc. (VNDA) Description

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders. Website:

News & Commentary Rss Feed

Why Vanda Pharmaceuticals inc. Shares Jumped 10% Today

Sequential growth for Vanda Pharmaceuticals two commercial drugs led to better than expected financial results last quarter.

Weekly CEO Sells Highlight: Cameron International, Envision Healthcare Holdings, Vanda ...

Vanda Pharmaceuticals Looks Attractive

Intra-Cellular Surges on Optimistic Outlook for Schizophrenia Drug

Vanda Announces FDA Has Accepted for Review the Fanapt Supplemental New Drug Application for Mainten

Vanda Announces FDA Has Accepted for Review the Fanapt Supplemental New Drug Application for Maintenance Treatment of Schizophrenia in Adults

Collegium's Xtampza Supported for Approval by FDA Panels

Vanda Pharmaceuticals (VNDA) Shares March Higher, Can It Continue?

Revance's Botulinum Toxin Type A Gel in Phase II Study

Vanda Announces Favorable Markman Ruling in FanaptĀ® Patent Infringement Litigation

Theravance, Glaxo SUMMIT Study Misses Primary Endpoint

Alnylam to Speed Up Development for Primary Hyperoxaluria

See More VNDA News...

VNDA's Top Competitors

VNDA $11.62 (5.06%)
Current stock: VNDA
AMGN $142.47 (1.60%)
Current stock: AMGN
GILD $98.28 (0.01%)
Current stock: GILD
BIIB $290.35 (1.06%)
Current stock: BIIB